A detailed history of E. Ohman J:Or Asset Management Ab transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 900 shares of BIO stock, worth $293,022. This represents 0.01% of its overall portfolio holdings.

Number of Shares
900
Previous 900 -0.0%
Holding current value
$293,022
Previous $246 Million 22.51%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$268.26 - $339.48 $134,130 - $169,740
500 Added 125.0%
900 $246 Million
Q3 2023

Feb 06, 2024

BUY
$350.25 - $422.63 $140,100 - $169,052
400 New
400 $143 Million
Q3 2022

Apr 05, 2024

SELL
$412.59 - $563.26 $453,849 - $619,586
-1,100 Closed
0 $0
Q2 2022

Apr 05, 2024

SELL
$463.67 - $597.16 $6.31 Million - $8.12 Million
-13,600 Reduced 92.52%
1,100 $545 Million
Q1 2022

Apr 05, 2024

SELL
$524.57 - $735.42 $1.73 Million - $2.43 Million
-3,300 Reduced 18.33%
14,700 $8.28 Billion
Q4 2021

Apr 05, 2024

SELL
$708.84 - $794.68 $676,233 - $758,124
-954 Reduced 5.03%
18,000 $13.6 Billion
Q3 2021

Apr 05, 2024

BUY
$657.71 - $825.77 $986,565 - $1.24 Million
1,500 Added 8.59%
18,954 $14.1 Billion
Q2 2021

Apr 05, 2024

BUY
$576.64 - $649.04 $9.51 Million - $10.7 Million
16,500 Added 1729.56%
17,454 $11.2 Billion
Q3 2020

Apr 05, 2024

BUY
$454.43 - $535.6 $136,329 - $160,680
300 Added 45.87%
954 $492 Million
Q1 2020

Apr 05, 2024

SELL
$320.01 - $409.07 $192,006 - $245,442
-600 Reduced 47.85%
654 $229 Million
Q4 2019

Apr 05, 2024

BUY
$319.73 - $374.2 $273,049 - $319,566
854 Added 213.5%
1,254 $464 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.02B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.